Original article
NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma
Gustavo Nery de Queiroza, Keli Limaa,b, Livia Bassani Lins de Mirandaa, Eduardo Magalhães Regob,c, Fabiola Trainac,d, João Agostinho Machado-Netoa,
Autor para correspondência
jamachadoneto@usp.br
Corresponding author at: Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524, CEP 05508-900, São Paulo, SP, Brazil.
Corresponding author at: Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524, CEP 05508-900, São Paulo, SP, Brazil.
a Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
b Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil
c Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil
d Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil
Lido
1471
Vezesque se leu este artigo
388
Total PDF
1083
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 35 | 9 | 44 |
| 2025 5 | 92 | 11 | 103 |
| 2025 4 | 64 | 17 | 81 |
| 2025 3 | 81 | 16 | 97 |
| 2025 2 | 53 | 23 | 76 |
| 2025 1 | 39 | 15 | 54 |
| 2024 12 | 38 | 27 | 65 |
| 2024 11 | 66 | 22 | 88 |
| 2024 10 | 50 | 21 | 71 |
| 2024 9 | 90 | 24 | 114 |
| 2024 8 | 81 | 32 | 113 |
| 2024 7 | 86 | 62 | 148 |
| 2024 6 | 94 | 27 | 121 |
| 2024 5 | 79 | 35 | 114 |
| 2024 4 | 94 | 18 | 112 |
| 2024 3 | 41 | 29 | 70 |
Mostrar tudo
